Rational Development of NAMPT/PARP1 Dual Inhibitors Targeting NAD Metabolism for Breast Cancer Therapy
Bulletin of Pioneering Researches of Medical and Clinical Science · 2025 · 5 (2) · 202-223
DOI: 10.51847/hc2kbdacqu ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of Pioneering Researches of Medical and Clinical Science, 2025. Verfasst von Jinwoo Park und 2 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Park, J., Kim, M., & Lee, S. (2025). Rational Development of NAMPT/PARP1 Dual Inhibitors Targeting NAD Metabolism for Breast Cancer Therapy. Bulletin of Pioneering Researches of Medical and Clinical Science, 5(2), 202-223. https://doi.org/10.51847/hc2kbdacqu
Vancouver
Park J, Kim M, Lee S. Rational Development of NAMPT/PARP1 Dual Inhibitors Targeting NAD Metabolism for Breast Cancer Therapy. Bulletin of Pioneering Researches of Medical and Clinical Science. 2025;5(2):202-223. doi:10.51847/hc2kbdacqu
BibTeX
@article{Park2025,
author = {Park, Jinwoo and Kim, Minji and Lee, Seung},
title = {Rational Development of NAMPT/PARP1 Dual Inhibitors Targeting NAD Metabolism for Breast Cancer Therapy},
journal = {Bulletin of Pioneering Researches of Medical and Clinical Science},
year = {2025},
volume = {5},
number = {2},
pages = {202--223},
doi = {10.51847/hc2kbdacqu}
}
EUVIMED